191 related articles for article (PubMed ID: 24814900)
1. Is off-pump coronary artery bypass grafting superior to drug-eluting stents for the treatment of coronary artery disease? A meta-analysis of randomized and nonrandomized studies.
Lu D; Nie X; Wan J; He S; Du S; Zhang Z; Wang Z; Wang W
Int J Cardiol; 2014 Jul; 174(3):640-53. PubMed ID: 24814900
[TBL] [Abstract][Full Text] [Related]
2. Late thrombosis after double versus single drug-eluting stent in the treatment of coronary bifurcations: a meta-analysis of randomized and observational Studies.
Zimarino M; Corazzini A; Ricci F; Di Nicola M; De Caterina R
JACC Cardiovasc Interv; 2013 Jul; 6(7):687-95. PubMed ID: 23769650
[TBL] [Abstract][Full Text] [Related]
3. Revascularization in left main coronary artery disease: comparison of off-pump coronary artery bypass grafting vs percutaneous coronary intervention.
Jeong DS; Lee YT; Chung SR; Jeong JH; Kim WS; Sung K; Park PW
Eur J Cardiothorac Surg; 2013 Oct; 44(4):718-24. PubMed ID: 23423919
[TBL] [Abstract][Full Text] [Related]
4. Stent versus off-pump coronary bypass grafting in the second-generation drug-eluting stent era.
Yi G; Joo HC; Youn YN; Hong S; Yoo KJ
Ann Thorac Surg; 2013 Aug; 96(2):535-41. PubMed ID: 23622702
[TBL] [Abstract][Full Text] [Related]
5. Comparison of off-pump coronary artery bypass grafting with percutaneous coronary intervention versus drug-eluting stents for three-vessel coronary artery disease.
Yi G; Youn YN; Yoo KJ; Hong YS
Ann Thorac Surg; 2008 Nov; 86(5):1438-43. PubMed ID: 19049727
[TBL] [Abstract][Full Text] [Related]
6. A review with meta-analysis of observational studies for survival following off-pump coronary artery bypass versus drug-eluting stent implantation.
Takagi H; Watanabe T; Mizuno Y; Kawai N; Umemoto T;
Interact Cardiovasc Thorac Surg; 2014 Jun; 18(6):807-13. PubMed ID: 24591399
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of randomized controlled trials on the treatment of unprotected left main coronary artery disease: one-year outcomes with coronary artery bypass grafting versus percutaneous coronary artery intervention with drug-eluting stent.
Kajimoto K; Miyauchi K; Yamamoto T; Daida H; Amano A
J Card Surg; 2012 Mar; 27(2):152-7. PubMed ID: 22364383
[TBL] [Abstract][Full Text] [Related]
8. Off-pump coronary artery bypass grafting improves short-term outcomes in high-risk patients compared with on-pump coronary artery bypass grafting: Meta-analysis.
Kowalewski M; Pawliszak W; Malvindi PG; Bokszanski MP; Perlinski D; Raffa GM; Kowalkowska ME; Zaborowska K; Navarese EP; Kolodziejczak M; Kowalewski J; Tarelli G; Taggart DP; Anisimowicz L
J Thorac Cardiovasc Surg; 2016 Jan; 151(1):60-77.e1-58. PubMed ID: 26433633
[TBL] [Abstract][Full Text] [Related]
9. Comparison of long-term outcome of off-pump coronary artery bypass grafting versus drug-eluting stents in triple-vessel coronary artery disease.
Yi G; Youn YN; Hong S; Song SW; Yoo KJ
Am J Cardiol; 2012 Mar; 109(6):819-23. PubMed ID: 22177004
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) Registry.
Park DW; Kim YH; Yun SC; Lee JY; Kim WJ; Kang SJ; Lee SW; Lee CW; Kim JJ; Choo SJ; Chung CH; Lee JW; Park SW; Park SJ
J Am Coll Cardiol; 2010 Oct; 56(17):1366-75. PubMed ID: 20946993
[TBL] [Abstract][Full Text] [Related]
11. Midterm outcome of off-pump bypass procedures versus drug-eluting stent for unprotected left main coronary artery disease.
Yi G; Youn YN; Hong S; Song SW; Yoo KJ
Ann Thorac Surg; 2012 Jul; 94(1):15-22. PubMed ID: 22542069
[TBL] [Abstract][Full Text] [Related]
12. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
[TBL] [Abstract][Full Text] [Related]
13. Comparing outcomes after off-pump coronary artery bypass versus drug-eluting stent in diabetic patients.
Dohi S; Kajimoto K; Miyauchi K; Yamamoto T; Tambara K; Inaba H; Kuwaki K; Tamura H; Kojima T; Yokoyama K; Kurata T; Daida H; Amano A
J Cardiol; 2012 Mar; 59(2):195-201. PubMed ID: 22316549
[TBL] [Abstract][Full Text] [Related]
14. Drug-eluting stents versus coronary artery bypass grafting for the treatment of coronary artery disease: a meta-analysis of randomized and nonrandomized studies.
Yan TD; Padang R; Poh C; Cao C; Wilson MK; Bannon PG; Vallely MP
J Thorac Cardiovasc Surg; 2011 May; 141(5):1134-44. PubMed ID: 21167508
[TBL] [Abstract][Full Text] [Related]
15. Revascularization of left anterior descending coronary artery in patients with single and multivessel disease: comparison between off-pump internal thoracic artery and drug-eluting stent.
Moshkovitz Y; Mohr R; Braunstein R; Zivi E; Uretzky G; Ben-Gal Y; Herz I
Chest; 2005 Aug; 128(2):804-9. PubMed ID: 16100171
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of zotarolimus-eluting stents compared with sirolimus-eluting stents in patients undergoing percutaneous coronary interventions--a meta-analysis of randomized controlled trials.
Fan J; Du H; Yin Y; Ling Z; Wu J; Xiao P; Zrenner B
Int J Cardiol; 2013 Sep; 167(5):2126-33. PubMed ID: 22703941
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
Dangas GD; Serruys PW; Kereiakes DJ; Hermiller J; Rizvi A; Newman W; Sudhir K; Smith RS; Cao S; Theodoropoulos K; Cutlip DE; Lansky AJ; Stone GW
JACC Cardiovasc Interv; 2013 Sep; 6(9):914-22. PubMed ID: 24050859
[TBL] [Abstract][Full Text] [Related]
18. Meta-Analysis of Randomized Control Trials Comparing Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Significant Left Main Coronary Narrowing.
Qian C; Feng H; Cao J; Wei B; Wang Y
Am J Cardiol; 2017 May; 119(9):1338-1343. PubMed ID: 28267960
[TBL] [Abstract][Full Text] [Related]
19. Clampless off-pump surgery reduces stroke in patients with left main disease.
Emmert MY; Salzberg SP; Seifert B; Scherman J; Plass A; Starck CT; Theusinger O; Hoerstrup SP; Grünenfelder J; Jacobs S; Falk V
Int J Cardiol; 2013 Sep; 167(5):2097-101. PubMed ID: 22726394
[TBL] [Abstract][Full Text] [Related]
20. Drug-eluting stents versus coronary artery bypass graft surgery in left main coronary artery disease: a meta-analysis of early outcomes from randomized and nonrandomized studies.
Cao C; Manganas C; Bannon P; Vallely M; Yan TD
J Thorac Cardiovasc Surg; 2013 Mar; 145(3):738-47. PubMed ID: 22405674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
